|
US4370983A
(en)
*
|
1971-01-20 |
1983-02-01 |
Lichtenstein Eric Stefan |
Computer-control medical care system
|
|
DE2737922A1
(de)
*
|
1977-08-23 |
1979-03-08 |
Fresenius Chem Pharm Ind |
Kuenstliche endokrine druese
|
|
US4151845A
(en)
*
|
1977-11-25 |
1979-05-01 |
Miles Laboratories, Inc. |
Blood glucose control apparatus
|
|
US4469681A
(en)
*
|
1979-07-31 |
1984-09-04 |
The Rockefeller University |
Method and system for the controlled release of biologically active substances to a body fluid
|
|
US4348387A
(en)
*
|
1979-07-31 |
1982-09-07 |
The Rockefeller University |
Method and system for the controlled release of biologically active substances to a body fluid
|
|
JPS58198351A
(ja)
*
|
1982-05-15 |
1983-11-18 |
株式会社京都第一科学 |
希釈される体液中の特定成分を連続的に測定する装置
|
|
JPS598969A
(ja)
*
|
1982-07-09 |
1984-01-18 |
藤沢薬品工業株式会社 |
人工膵臓
|
|
FR2531333B1
(fr)
*
|
1982-08-09 |
1986-04-04 |
Centre Nat Rech Scient |
Pancreas bio-artificiel a ultrafiltration
|
|
DD230730A3
(de)
*
|
1984-01-02 |
1985-12-11 |
Zentralinstitut Fuer Diabetes |
Einrichtung zur prospektiven automatischen bestimmung individualspezifischer glukoseregulationsparameter
|
|
CA1254091A
(fr)
*
|
1984-09-28 |
1989-05-16 |
Vladimir Feingold |
Systeme implantable pour la perfusion de medicaments
|
|
DE3545260A1
(de)
*
|
1985-12-20 |
1987-06-25 |
Juergen Schrezenmeir |
Vorrichtung zur kontinuierlichen oder diskontinuierlichen verabreichung von insulin in den menschlichen koerper
|
|
GB8818690D0
(en)
*
|
1988-08-05 |
1988-09-07 |
Red Kite Technology Ltd |
Refractive index measurement
|
|
US7037277B1
(en)
|
1998-07-21 |
2006-05-02 |
Spectrx, Inc. |
System and method for fluid management in a continuous fluid collection and sensor device
|
|
US7384396B2
(en)
|
1998-07-21 |
2008-06-10 |
Spectrx Inc. |
System and method for continuous analyte monitoring
|
|
AUPR632301A0
(en)
*
|
2001-07-11 |
2001-08-02 |
Chee, Frederick Howe-Hui |
Infusion apparatus for regulating blood glucose levels
|
|
US7509156B2
(en)
|
2005-05-18 |
2009-03-24 |
Clarian Health Partners, Inc. |
System for managing glucose levels in patients with diabetes or hyperglycemia
|
|
US8417311B2
(en)
|
2008-09-12 |
2013-04-09 |
Optiscan Biomedical Corporation |
Fluid component analysis system and method for glucose monitoring and control
|
|
CA2702116C
(fr)
|
2007-10-10 |
2021-01-05 |
Optiscan Biomedical Corporation |
Systeme d'analyse de composant de fluide et procede pour controler et reguler le glucose
|
|
US7959598B2
(en)
|
2008-08-20 |
2011-06-14 |
Asante Solutions, Inc. |
Infusion pump systems and methods
|
|
US9561324B2
(en)
|
2013-07-19 |
2017-02-07 |
Bigfoot Biomedical, Inc. |
Infusion pump system and method
|
|
GB2523989B
(en)
|
2014-01-30 |
2020-07-29 |
Insulet Netherlands B V |
Therapeutic product delivery system and method of pairing
|
|
CN111905188B
(zh)
|
2015-02-18 |
2022-07-22 |
英赛罗公司 |
流体输送和输注装置及其使用方法
|
|
WO2017123525A1
(fr)
|
2016-01-13 |
2017-07-20 |
Bigfoot Biomedical, Inc. |
Interface utilisateur pour système de gestion du diabète
|
|
HK1256995A1
(zh)
|
2016-01-14 |
2019-10-11 |
Bigfoot Biomedical, Inc. |
药物输送设备、系统和方法中的阻塞解决方案
|
|
US10806859B2
(en)
|
2016-01-14 |
2020-10-20 |
Bigfoot Biomedical, Inc. |
Adjusting insulin delivery rates
|
|
US12383166B2
(en)
|
2016-05-23 |
2025-08-12 |
Insulet Corporation |
Insulin delivery system and methods with risk-based set points
|
|
US10765807B2
(en)
|
2016-09-23 |
2020-09-08 |
Insulet Corporation |
Fluid delivery device with sensor
|
|
US11096624B2
(en)
|
2016-12-12 |
2021-08-24 |
Bigfoot Biomedical, Inc. |
Alarms and alerts for medication delivery devices and systems
|
|
EP3568860B1
(fr)
|
2017-01-13 |
2025-12-10 |
Insulet Corporation |
Méthodes, systèmes et dispositifs d'administration d'insuline
|
|
US10500334B2
(en)
|
2017-01-13 |
2019-12-10 |
Bigfoot Biomedical, Inc. |
System and method for adjusting insulin delivery
|
|
US10583250B2
(en)
|
2017-01-13 |
2020-03-10 |
Bigfoot Biomedical, Inc. |
System and method for adjusting insulin delivery
|
|
US10881792B2
(en)
|
2017-01-13 |
2021-01-05 |
Bigfoot Biomedical, Inc. |
System and method for adjusting insulin delivery
|
|
US11033682B2
(en)
|
2017-01-13 |
2021-06-15 |
Bigfoot Biomedical, Inc. |
Insulin delivery methods, systems and devices
|
|
US10758675B2
(en)
|
2017-01-13 |
2020-09-01 |
Bigfoot Biomedical, Inc. |
System and method for adjusting insulin delivery
|
|
USD928199S1
(en)
|
2018-04-02 |
2021-08-17 |
Bigfoot Biomedical, Inc. |
Medication delivery device with icons
|
|
US11565043B2
(en)
|
2018-05-04 |
2023-01-31 |
Insulet Corporation |
Safety constraints for a control algorithm based drug delivery system
|
|
US12562251B1
(en)
|
2018-05-09 |
2026-02-24 |
Bigfoot Biomedical, Inc. |
Computing architecture for assuring the provenance of medication therapy related parameters, and related systems, methods and devices
|
|
AU2019347755B2
(en)
|
2018-09-28 |
2023-02-02 |
Insulet Corporation |
Activity mode for artificial pancreas system
|
|
EP3864668A1
(fr)
|
2018-10-11 |
2021-08-18 |
Insulet Corporation |
Détection d'événement pour système d'administration de médicament
|
|
USD920343S1
(en)
|
2019-01-09 |
2021-05-25 |
Bigfoot Biomedical, Inc. |
Display screen or portion thereof with graphical user interface associated with insulin delivery
|
|
US11801344B2
(en)
|
2019-09-13 |
2023-10-31 |
Insulet Corporation |
Blood glucose rate of change modulation of meal and correction insulin bolus quantity
|
|
US11935637B2
(en)
|
2019-09-27 |
2024-03-19 |
Insulet Corporation |
Onboarding and total daily insulin adaptivity
|
|
EP4069082B1
(fr)
|
2019-12-06 |
2024-06-05 |
Insulet Corporation |
Techniques et dispositifs de fourniture d'adaptabilité et de personnalisation dans le traitement du diabète
|
|
US11833329B2
(en)
|
2019-12-20 |
2023-12-05 |
Insulet Corporation |
Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
|
|
JP7512395B2
(ja)
|
2020-01-06 |
2024-07-08 |
インスレット コーポレイション |
持続する残差に基づく食事および/または運動行為の予測
|
|
EP4100958A1
(fr)
|
2020-02-03 |
2022-12-14 |
Insulet Corporation |
Utilisation d'une logique floue pour prédire un comportement d'utilisateur affectant la glycémie
|
|
US11551802B2
(en)
|
2020-02-11 |
2023-01-10 |
Insulet Corporation |
Early meal detection and calorie intake detection
|
|
US11547800B2
(en)
|
2020-02-12 |
2023-01-10 |
Insulet Corporation |
User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
|
|
US11986630B2
(en)
|
2020-02-12 |
2024-05-21 |
Insulet Corporation |
Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk
|
|
US11324889B2
(en)
|
2020-02-14 |
2022-05-10 |
Insulet Corporation |
Compensation for missing readings from a glucose monitor in an automated insulin delivery system
|
|
US12495994B2
(en)
|
2020-02-20 |
2025-12-16 |
Insulet Corporation |
Meal bolus subcategories in model based insulin therapy
|
|
US11607493B2
(en)
|
2020-04-06 |
2023-03-21 |
Insulet Corporation |
Initial total daily insulin setting for user onboarding
|
|
US12121700B2
(en)
|
2020-07-22 |
2024-10-22 |
Insulet Corporation |
Open-loop insulin delivery basal parameters based on insulin delivery records
|
|
US11684716B2
(en)
|
2020-07-31 |
2023-06-27 |
Insulet Corporation |
Techniques to reduce risk of occlusions in drug delivery systems
|
|
US12569619B2
(en)
|
2020-09-21 |
2026-03-10 |
Insulet Corporation |
Techniques for determining automated insulin delivery dosages
|
|
EP4696344A3
(fr)
|
2020-09-30 |
2026-04-15 |
Insulet Corporation |
Dispositif d'administration de médicament à glucomètre optique intégré
|
|
US12115351B2
(en)
|
2020-09-30 |
2024-10-15 |
Insulet Corporation |
Secure wireless communications between a glucose monitor and other devices
|
|
US11160925B1
(en)
|
2021-01-29 |
2021-11-02 |
Insulet Corporation |
Automatic drug delivery system for delivery of a GLP-1 therapeutic
|
|
US11904140B2
(en)
|
2021-03-10 |
2024-02-20 |
Insulet Corporation |
Adaptable asymmetric medicament cost component in a control system for medicament delivery
|
|
EP4305636A1
(fr)
|
2021-03-10 |
2024-01-17 |
Insulet Corporation |
Dispositif d'administration de médicament ayant une composante de coût de niveau d'analyte réglable et par segments pour répondre aux écarts de niveau d'analyte positifs persistants
|
|
US12592306B2
(en)
|
2021-04-28 |
2026-03-31 |
Insulet Corporation |
Devices and methods for initialization of drug delivery devices using measured analyte sensor information
|
|
US12496398B2
(en)
|
2021-05-28 |
2025-12-16 |
Insulet Corporation |
Threshold based automatic glucose control response
|
|
EP4101482A1
(fr)
|
2021-06-07 |
2022-12-14 |
Insulet Corporation |
Prédiction de sécurité d'exercice basée sur les conditions physiologiques
|
|
US12514980B2
(en)
|
2021-06-30 |
2026-01-06 |
Insulet Corporation |
Adjustment of medicament delivery by a medicament delivery device based on menstrual cycle phase
|
|
US12521486B2
(en)
|
2021-07-16 |
2026-01-13 |
Insulet Corporation |
Method for modification of insulin delivery during pregnancy in automatic insulin delivery systems
|
|
WO2023049900A1
(fr)
|
2021-09-27 |
2023-03-30 |
Insulet Corporation |
Techniques permettant l'adaptation de paramètres dans des systèmes d'aide par entrée d'utilisateur
|
|
US11439754B1
(en)
|
2021-12-01 |
2022-09-13 |
Insulet Corporation |
Optimizing embedded formulations for drug delivery
|
|
EP4243030A1
(fr)
|
2022-03-09 |
2023-09-13 |
Insulet Corporation |
Ajustement de paramètres d'administration de médicament dans un mode d'administration de médicament en boucle ouverte
|
|
EP4646726A1
(fr)
|
2023-01-06 |
2025-11-12 |
Insulet Corporation |
Administration de bolus de repas lancée automatiquement ou manuellement avec assouplissement automatique ultérieur des contraintes de sécurité
|